Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Free Cash Flow: 2021-2025

Historic Free Cash Flow for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to -$844.0 million.

  • Roivant Sciences' Free Cash Flow rose 27.74% to -$193.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 1.84%. This contributed to the annual value of -$844.0 million for FY2025, which is 10.10% down from last year.
  • As of FY2025, Roivant Sciences' Free Cash Flow stood at -$844.0 million, which was down 10.10% from -$766.6 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Free Cash Flow ranged from a high of -$557.9 million in FY2021 and a low of -$856.1 million during FY2023.
  • Over the past 3 years, Roivant Sciences' median Free Cash Flow value was -$844.0 million (recorded in 2025), while the average stood at -$822.3 million.
  • As far as peak fluctuations go, Roivant Sciences' Free Cash Flow declined by 24.59% in 2022, and later climbed by 10.45% in 2024.
  • Roivant Sciences' Free Cash Flow (Yearly) stood at -$557.9 million in 2021, then declined by 24.59% to -$695.2 million in 2022, then fell by 23.15% to -$856.1 million in 2023, then grew by 10.45% to -$766.6 million in 2024, then declined by 10.10% to -$844.0 million in 2025.